Clearpoint Neuro: Rises on higher prelim Q4 revenue forecast
13/01/2021 18:04
** Shares of medical device co CLPT.O up 3.7% at $16.02,
gain for a second consecutive day
** CLPT expects preliminary Q4 revenue to be about $3.7 mln,
a 14% rise from a year earlier, and higher than Wall Street
estimates urn:newsml:reuters.com:*:nGNX1FvNXS
** Co on Tuesday aftermarket forecast FY 2020 preliminary
revenue of $12.8 mln, 14% higher from a year earlier
** Clearpoint Neuro, however, says it continues to see an
adverse impact on the co from the recent surge in COVID-19 cases
globally
** Expects downward pressure on elective procedures to
continue at least through the first half of 2021
** Stock has risen over 160% in the past year
(Reporting by Arundhati Sarkar in Bengaluru)
((Arundhati.Sarkar@thomsonreuters.com;
twitter.com/Arundhati_05; +1 646 223 8780 Ext: 2776))